All Articles

There are more treatment options available for breast cancer than ever before – and more are coming. Here’s an overview of the most recently approved medicines. Read More ›

ER? PR? HR? We can help you make sense of the “alphabet soup” of a breast cancer diagnosis. Read More ›

From meals to carpools, your community can help make life a little easier. Read More ›

In May 2019, Kiana Wooten went for a routine check-up. Read about how that routine visit turned into a breast cancer diagnosis for the 34-year-old Kiana, who had to be hospitalized during COVID-19. Read More ›

Learning about lung cancer risks is important. An issue that needs more awareness is occupational exposure to harmful chemicals and the negative effects such exposure has on our health. Read More ›

The immunotherapy Libtayo received FDA approval as first-line treatment for patients with advanced or metastatic non–small-cell lung cancer and high PD-L1 expression. Read More ›

The immunotherapy Libtayo is a new treatment option for advanced or metastatic basal-cell carcinoma, a type of skin cancer. Libtayo was initially approved for a different type of skin cancer. Read More ›

Sabrina Steinback’s mom died from COVID-19 in 2020, and then Sabrina had a lumpectomy to remove breast cancer at the end of the year. Read More ›

Pepaxto is a novel therapy that has shown good results in multiple myeloma that does not respond to other therapies, according to myeloma expert Paul G. Richardson, MD, of Dana-Farber Cancer Institute. Read More ›

Abecma is the first gene therapy approved by the FDA for patients with multiple myeloma. It uses the patient’s own genetically modified T-cells to fight the cancer. Read More ›